Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model

Ítems similars

• A combination of sorafenib and radiotherapy reduces NF-κB activity and growth of hepatocellular carcinoma in an orthotopic mouse model
  per: Chuang, Hui-Yen, et al.
  Publicat: (2021)
• Enhanced cytotoxicity of human hepatocellular carcinoma cells following pretreatment with sorafenib combined with trichostatin A
  per: Chen, John Chun-Hao, et al.
  Publicat: (2019)
• Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway
  per: Chuang, Hui-Yen, et al.
  Publicat: (2019)
• S1P promotes IL-6 expression in osteoblasts through the PI3K, MEK/ERK and NF-κB signaling pathways
  per: Hu, Sung-Lin, et al.
  Publicat: (2020)
• Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice
  per: Hsu, Fei-Ting, et al.
  Publicat: (2015)